# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Accuray Incorporated (NASDAQ:ARAY) announced today that the registration dossier for the Accuray Precision® Treatment Planning...
Accuray (NASDAQ:ARAY) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $(0.01) by ...
Roth MKM analyst Jason Wittes initiates coverage on Accuray (NASDAQ:ARAY) with a Buy rating and announces Price Target of $9.